OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Cardiology is 60. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Anticipating Pharmacological Perturbation With Human Genetic Variation—Lessons From CETP	277
A Woman With Recurrent Torsade de Pointes	244
A Patient in His 50s With Chest Tightness and Left Arm and Neck Tingling	235
The Case for Inclusion of a Lipid Panel in the Standard Precatheterization Laboratory Blood Draw—Stating What Should Be Obvious	196
Primary Prevention Management of Elevated Lipoprotein(a)	186
Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction—Reply	178
Error in Table 1	168
Educational Attainment and Cardiovascular Risk—A Missed Opportunity?	163
JAMA Cardiology	158
Mendelian Randomization and Cardiovascular Disease—Enabling Expert Readership	157
Ventricular Septal Rupture After ST-Segment Elevation Myocardial Infarction	149
Implementing Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy	147
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event—Moving Beyond C Statistic	137
Chest Pain in a Middle-Aged Man	137
Finding Pulmonary Arterial Hypertension—Switching to Offense to Mitigate Disease Burden	135
Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure	129
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF	128
Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors	128
Genome-Wide Association Study of Accessory Atrioventricular Pathways	111
JAMA Cardiology	111
USPSTF Report on Aspirin for Primary Prevention	106
Mining the Electronic Medical Record for Hypertension Treatment—Hope or Hype?	101
Accountable Care Organization Participation and Cardiovascular Care Quality	101
Blood Pressure Measurements From Self-Service Health Kiosks in US Retail Stores, 2017-2024	98
Smoking Cessation Improves Outcomes in Patients With Peripheral Artery Disease	98

Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes	96
Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial Infarction	93
Spontaneous Coronary Artery Dissection in a Healthy Man With Non–ST Elevation Myocardial Infarction	92
JAMA Cardiology	91
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	91
Assessing Performance of Machine Learning—Reply	90
Supraventricular Tachycardia Following Mitral Valve Surgery	89
JAMA Cardiology	88
Hypertriglyceridemia in the MESA Study—Reply	87
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target—Reply	87
What Is Your Secret to Health?	87
Innovation in Event Adjudication—Human vs Machine	86
Interpreting Health Status Measures in Patients With Heart Failure—What Counts	85
Peak Oxygen Uptake vs Ventilatory Efficiency	83
Contribution of Clinical Trial Event Data by Data Source	82
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?	81
Race, Racism, and Risk—Implications of Social Determinants of Health in Cardiovascular Disease Prediction	81
User Trust in Artificial Intelligence–Guided Lung Ultrasound	80
Critical Appraisal of the Negative Predictive Performance of the European Society of Cardiology 0/1-Hour Algorithm for Evaluating Patients With Chest Pain in the US	79
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features	79
Artificial Intelligence–Guided Lung Ultrasound by Nonexperts	77
Left Atrial Appendage Closure After Thrombus Aspiration—Reply	74
Circulating Trimethylamine N-Oxide and Growth Rate of Abdominal Aortic Aneurysms and Surgical Risk	73
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone	73
Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm	72
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease	69
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction	67
Change to Open Access Status	65
A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy–Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer	65
Corrected to Open Access Status	64
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	64
Achieving Equitable Access to Acute Myocardial Infarction Therapies for Rural Patients—Is It Possible?	63
Safety of the 4PEPS in Patients With a Very Low Prevalence of Pulmonary Embolism—Need for More Than a Point Estimate—Reply	62
Young Man With Coarctation of the Aorta	61
Error in Figure	61
JAMA Cardiology	60
Optimizing Cascade Testing to Advance Health Equity in Cardiac Amyloidosis	60
PCSK9 in Familial Hypercholesterolemia and Beyond	60